PRESENTATIONS

2018

Regier, D. Uncertainty and Utility for Precision Medicine Outcomes. Uncertainty and the Value of Precision Medicine, Precision Medicine Policy Network workshop held at the HTAi 2018 Annual Meeting, Vancouver British Columbia. June 2, 2018.

Shinkins, B. Uncertainty in Precision Diagnostics. Uncertainty and the Value of Precision Medicine, Precision Medicine Policy Network workshop held at the HTAi 2018 Annual Meeting, Vancouver British Columbia. June 2, 2018.

Smith, A.F. Uncertainty in the Laboratory: Evaluation of Test Measurement Uncertainty in HTA. Uncertainty and the Value of Precision Medicine, Precision Medicine Policy Network workshop held at the HTAi 2018 Annual Meeting, Vancouver British Columbia. June 2, 2018.

McCabe C. Genetics and Health in Alberta: Demonstrated Value and Future Opportunities. Government of Alberta, Edmonton, AB. Mar 27, 2018.

McCabe C., Paulden, M. Developing Technologies that We Can’t Afford: Can Value-based Pricing Help? Network of Alberta Health Economists (NOAHE), Edmonton, AB. Mar 21, 2018. (view presentation)

Wilson, B.  Precision Medicine: Observations from an Implementation Science Perspective. Value of Information / Value of Implementation for Outcomes-focused Precision Health, Precision Medicine Policy Network workshop, Banff, AB. Feb 6-8, 2018.

McCabe C. Precision Medicine, Value, and Implementation: Challenges and Opportunities. Value of Information / Value of Implementation for Outcomes-focused Precision Health, Precision Medicine Policy Network workshop, Banff, AB. Feb 6-8, 2018.

2017

McCabe C. Health Economics and the Clinical Translation of Stem Cell Technologies. CCRM, Mount Tremblant, QC. Nov 10, 2017

McCabe C. Life Cycle Technology Assessment Frameworks for Precision Medicine Technology. Canadian Cancer Research Conference, Vancouver, BC. Nov 5, 2017.

Wilson, B. Building Better Implementation to Improve Health and Sustainability. Canadian Cancer Research Conference, Vancouver, BC. Nov 5, 2017.

McCabe C. Future of Personalized Health – Tomorrow’s Promises – Today’s Challenges. Drug Information Association (DIA) Annual Canadian Meeting, Ottawa, ON. Oct 18, 2017.

McCabe C. Life Cycle Health Technology Assessment: Can Payers Manage what Regulators Give Them? Health Canada, Ottawa, ON. Oct 18, 2017.

McCabe C. Reflections and Recommendations for Future Research: Identifying Research Priorities. Uncertainty in Value Assessment of Precision Medicine, Precision Medicine Policy Network workshop, Calgary, AB. Oct 12-13, 2017.

Paulden, M. Uncertainty in Implementation. Uncertainty in Value Assessment of Precision Medicine, Precision Medicine Policy Network workshop, Calgary, AB. Oct 12-13, 2017.

McCabe C. Uncertainty in Precision Medicine: An Ooverview. Uncertainty in Value Assessment of Precision Medicine, Precision Medicine Policy Network workshop, Calgary, AB. Oct 12-13, 2017.

Rahimzadeh, V., Knoppers, BM. Chained to the Block or Saved By It? Re-imagining Blockchain to Facilitate Mutual Recognition in Research Ethics Governance for the Data Intensive Sciences [invited]. Global Biobank Week, Stockholm, Sweden. Sept 14, 2017.

Paulden, M. Incorporating Clinician Behaviour into Precision Medicine Evaluations. Workshop: The Economics of Precision Medicine: Accounting for Imperfect Uptake and Assessing Value of Implementation, University of Leeds, UK. Sept 5, 2017.

Wilson, B. Implementing Precision Mmedicine – Success and Failure in Alberta, Canada. Workshop: The Economics of Precision Medicine: Accounting for Imperfect Uptake and Assessing Value of Implementation, University of Leeds, UK. Sept 5, 2017.

McCabe C. Developments in Alberta: Precision Medicine GeoLab. Workshop: The Economics of Precision Medicine: Accounting for Imperfect Uptake and Assessing Value of Implementation, University of Leeds, UK. Sept 5, 2017.

Votova, K. How the Goals of Precision Medicine should be Consistent with the Goal of Preventing Overdiagnosis. Workshop – Precision medicine and preventing overdiagnosis: Concordance or paradox? Preventing Overdiagnosis, Quebec City, QC. August 19, 2017.

McCabe C. Challenges for Healthcare Payers and Developers in Evaluating and Funding Precision Medicines. Risk-sharing Models to Advance Payer Paradigms for Precision Medicines, Precision Medicine Policy Network workshop, Banff, AB. June 27-29, 2017.

Ravitsky, V. To your health! Personalized Medicine in the Genomics Era. Café Scientifique, Canadian Bioethics Society annual meeting, Montreal, QC. May 24, 2017.

McCabe C. CADTH Health Economics Guidelines: What’s New? [panel]. 2017 CADTH Symposium, Ottawa, ON. April 24, 2017.

McCabe C., Bubela, T. Precision Medicine: Applying Theory to Practice for Value with Companion Diagnostics [panel]. 2017 CADTH Symposium, Ottawa, ON. April 24, 2017.

McCabe C. Measuring Value in Theory and the Real World [invited plenary]. 2017 CADTH Symposium, Ottawa, ON. April 24, 2017.

McCabe C. National Pharmacare – Lessons from the UK NHS [invited]. Medicines for All, Ottawa. ON. April 10-11, 2017.

McCabe C. Personalized Medicine and the Challenges of Getting Therapies into Clinical Trials and Beyond [invited]. Presentation to STEM High School Students, Toronto, ON. March 10, 2017.

Bubela, T. Making Cell and Gene Therapy Happen in Canada… Who Will Pay and How Much [invited keynote]. CellCAN’s First PanCanadian Strategic Forum on Cell and Gene Therapy. Montreal, QC. March 9-10, 2017.

Bubela, T. Governance of Biomedical Research Commons: Lessons from Laboratory Mice and DNA Barcodes [invited]. Ecology and Evolution Seminar Series, Department of Biological Science, University of Alberta. February 17, 2017

Wilson, B. Knowledge Translation Issues in Personal Genomics [invited]. Centre for Health Law, Policy and Ethics/School of Epidemiology and Public Health joint symposium, Ottawa, ON. Feb 10, 2017.

Bubela, T. Precision Medicine for Alberta: Are We Systems Ready? Integrated Health Records: Improving Patient Care for Albertans [invited keynote]. COACH/ANHIX Conference, Calgary, AB. February 8, 2017.

Bubela, T. Translating Translation: Non Science Challenges from Bench to Bedside for Novel Biotherapeutics [invited]. Department of Biological Sciences, MSC Seminar Series, University of Alberta, Edmonton. January 20, 1016.

Votova, K. Teaching Translational Research to Medical Students [invited]. University of Victoria Island Medical Program, Victoria, BC. Jan 2, 2017

2016

Gold, R. The Context of Innovation. Innovation in Context Workshop, Montreal, QC. Nov 19, 2016.

McCabe C. Innovation Costs: Economic Challenges to Sustainable Implementation of Cell and Gene Therapy. CCRM/Stem Cell Network Workshop, Whistler, BC. October 24, 2016.

Regier, D. Measuring and Valuing the Benefit of PM Technologies. Precision Medicine Policy Network Theme 2 Workshop, Vancouver, BC. Oct 22, 2016. 

Wolfson, M. Evaluating ‘Stochastic’ Technologies. Precision Medicine Policy Network Theme 2 Workshop, Vancouver, BC. Oct 22, 2016. 

McCabe, C. Using Routine Resource Use Data for Economic Evaluation of PM. Precision Medicine Policy Network Theme 2 Workshop, Vancouver, BC. Oct 22, 2016. 

Rousseau, F. Evaluating Lab Developed Tests. Precision Medicine Policy Network, Theme 2 workshop, Vancouver, BC. Oct 22, 2016. 

McCabe, C. Case study: Evaluating Prosigna vs. Oncotype for Guided Chemotherapy in Alberta. Precision Medicine Policy Network, Theme 2 workshop, Vancouver, BC. Oct 22, 2016. 

Genuis, S.K., Rousseau, F., Knoppers, B., Wilson, B., Wolfson, M., Bubela, T., McCabe, C. Disseminating Best Practice in ELSI Research to Support the Translation and Uptake of High Value Precision Medicine Technologies in Canada: The Precision Medicine Policy Network [Poster]. American Society of Human Genetics 2016 Annual Meeting, Vancouver, BC. Oct 20, 2016.

Knoppers B. Variant Databases: Tripartite Responsibilities. 4th Plenary of the Global Alliance for Genomics and Health, Vancouver BC. Oct 16-18.

Knoppers B. Participant Unique Identifiers [invited]. 4th Plenary of the Global Alliance for Genomics and Health, Vancouver, BC. Oct 16-18.

McCabe, C. Considering Costs of Development in Precision Oncology. First Precision Oncology Symposium, Leeds, UK. Oct 1, 2016.

McCabe, C. Sustainable Funding of Treatments for Precision Medicines/Orphan Drugs [invited].  Canadian Drug Expert Committee, CADTH, Winnipeg, MB. July, 21 2016.

Joly, Y. Are Data Sharing and Privacy Protection Mutually Exclusive in Personalized Health Research? International Congress on Personalized Health Care, Montreal, QC. June 13-15, 2016.

Rousseau, F. Precision Medicine Policy Network: The Genome Canada GE3LS Network for PM [invited]. International Congress on Personalized Health Care. Montreal, QC. June 13-15, 2016.

Rahimazdeh V., Knoppers B. The principle of Mutual Recognition and Research Ethics Rview in the Era of Personalized Medicine: A Model Policy? International Congress on Personalized Health Care. Montreal, QC. June 13-15, 2016

McCabe, C. Developing Specialty Drugs for a Value Based Reimbursement Environment [invited]. Canadian Society for Pharmaceutical Sciences Conference. Vancouver, BC.  June 1, 2016.

McCabe, C. National Pharmacare Programme, Cost Containment, and Personalised/Precision Medicine [invited]. In-person witness; House of Commons Standing Committee on Health. Ottawa, ON. May 30, 2016.

Knoppers, B.M., Rahimzadeh, V., Junker, A., Zawati, M.H., Ravitsky, V., Heslegrave, R., Morin, K., Joly,Y., Petilion, W. Taking a Provincial, National and International Pulse of Research Ethics Review ‘Reciprocity’ [invited]. Canadian Bioethics Society Annual Conference. Toronto, ON. May 25, 2016.

McCabe, C. National Pharmacare Programme, Cost Containment, and Personalised/Precision Medicine [invited]. Briefing Note; House of Commons Standing Committee on Health. Ottawa, ON. May 4, 2016.

Bubela, T. Intellectual Asset Management Challenges for Precision Medicine. 2016 CADTH Symposium. Ottawa, ON. April 11, 2016.

Wilson, B. Building Better Implementation. 2016 CADTH Symposium. Ottawa, ON. April 11, 2016.

Wolfson, M. HE/HTA and Genome Canada’s Precision Medicine Projects. 2016 CADTH Symposium. Ottawa, ON. April 11, 2016.

Zawati, M. Streamlining Research Ethics Review: Quo Vadis. 2016 CADTH Symposium. Ottawa, ON. April 11, 2016.

McCabe, C. Precision Medicine Policy Network: The Genome Canada GE3LS Network for PM. 2016 CADTH Symposium. Ottawa, ON. April 11, 2016.